Skip to main content
High RiskFDAfda-F-0357-2023UNDECLARED ALLERGEN

Coconut Pandan Cheesecake Coconut Butter Biscuit Crust (4oz) - 6 60845 37071 5.

Category
Units Affected
23
Recall Date
January 25, 2023
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0357-2023.

Coconut Pandan cheesecake is recalled because Sulfite is not declared as a coconut milk s sub-ingredient and Coconut is not declared in the Contains statement.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0357-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Amlag & Quibuyen, Llc Dba Hood Famous Bake Shop or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0357-2023.

Amlag & Quibuyen, LLC dba Hood Famous Bake Shop

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Amlag & Quibuyen, Llc Dba Hood Famous Bake Shop Recall FAQ

Amlag & Quibuyen, Llc Dba Hood Famous Bake Shop is the subject of a dairy safety report: Coconut Pandan Cheesecake Coconut Butter Biscuit Crust (4oz) - 6 60845 37071 5.. The notice was published on January 25, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 23 units are potentially affected.